GlassScriptPhysician profile
Rajit Basu
NPI 1366532566
$55,032.39
in general payments reported to CMS, 2019-2025
7 companies · $20K in 2025
The $20K reported for 2025 was more than what 99% of Pediatric Critical Care Medicine providers received nationally (typical 2025 total: $71.68).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $74.92 · 2021: $2,100 · 2022: $1,600 · 2023: $107 · 2024: $31K · 2025: $20K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $22K · Education: $19K · Travel and Lodging: $7,770 · Food and Beverage: $1,687.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $22,350.50 |
| Education | $19,450.00 |
| Travel and Lodging | $7,770.24 |
| Food and Beverage | $1,686.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $31,404.25 | 2024 | Renal - Acute |
| Vantive US Healthcare LLC | $19,746.14 | 2025 | Renal - Acute |
| C. R. Bard, INC. & Subsidiaries | $2,100.00 | 2021 | |
| Potrero Medical, INC. | $1,600.00 | 2022 | |
| Nuwellis, INC. | $107.08 | 2023 | Aquadex Smartflow Console |
| La Jolla Pharmaceutical Company | $74.92 | 2020 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rajit Basu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.